Clinical & Pharma

The pharmaceutical industry has delivered an impressive showing in the third quarter of 2024, with several key players posting remarkable financial results that have captured the attention of investors and analysts alike. Leading the charge is Merck (NYSE:MRK), a titan in the branded

The Centers for Disease Control and Prevention (CDC) recently revised its webpage on autism, suggesting a potential link between vaccines and the condition—a claim long debunked by decades of scientific research, sparking widespread controversy. This change, directed under the oversight of Health

Today, we’re thrilled to sit down with Dr. James Maitland, a renowned expert in public health policy and vaccine regulation. With decades of experience navigating the complex intersection of government, science, and societal health, Dr. Maitland offers a unique perspective on the evolving landscape

For more than three decades, Gulf War Illness (GWI) has cast a long shadow over the lives of countless veterans who served in the 1990-1991 Persian Gulf War, leaving them grappling with a constellation of debilitating symptoms without clear answers or effective treatments. This condition, affecting

The Isobutyric Acid Market is experiencing an extraordinary surge, captivating industries worldwide with its versatile applications and strong growth potential, and it is drawing significant attention as a key player in modern industrial processes. Valued at USD 197.35 million in 2024, this market

In the quiet corners of homes, where daily life unfolds amidst familiar surroundings, an invisible threat may be lurking in the form of household chemicals that could influence serious health outcomes like breast cancer. Many individuals spend the majority of their time indoors, surrounded by